Clinical Trials Browser

Phase 2 × Lomustine × Dermatologic × Clear all

NCT00072345 2013-01-18

Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV Melanoma

Phase 2 Completed

Uveal Melanoma, Melanoma